New hormonal therapy for advanced breast cancer called Femara (Fe-MAR-a, letrozole)
September 1997
You'll see a new hormonal therapy for advanced breast cancer called Femara (Fe-MAR-a, letrozole).
Novartis is launching it now in both the U.S. and Canada.
Femara is for postmenopausal women whose cancer progresses... despite treatment with an antiestrogen such as tamoxifen (Nolvadex).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive